“ICMR along with NIV and a network of other partner Institutes is embarking on phase-3 clinical trials of recombinant dengue vaccine”, Union Health Sec said.
In a statement issued after the meeting, Union Health Secretary Apurva Chandra said that the BRICS Vaccine Research and Development Centre, established during India’s BRICS presidency, was dedicated to strengthening the health systems of BRICS member states